Real-world efficacy and predictors of response to modified electroconvulsive therapy in patients with depression aged ≤30 years: a retrospective observational study
Frontiers in Psychiatry · 20.11.2026 · 17
DOI: 10.3389/fpsyt.2026.1969515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 20.11.2026. Verfasst von Xiaoli Sun und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Modified electroconvulsive therapy (MECT) is an effective treatment for severe and treatment-resistant depression; however, real-world evidence on its efficacy and predictors in patients aged ≤30 years remains limited.
Methods
We retrospectively reviewed 39 inpatients aged ≤30 years (median age 17 years; 76.9% female) who received bitemporal MECT under etomidate–succinylcholine anesthesia at a single center between December 2024 and December 2025. The 17-item Hamilton Depression Rating Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA) were assessed before and after treatment. Response (≥50% reduction in HAMD-17) and remission (HAMD-17 ≤7) were the primary outcomes. Spearman correlations, multivariable logistic regression, 1000-resample nonparametric bootstrap, and sensitivity analyses were used to evaluate efficacy and predictors.
Results
HAMD-17 decreased from 28.5 ± 8.1 to 12.8 ± 6.9 (median 28→12; P<0.001) and HAMA from 19.0 ± 6.6 to 8.4 ± 5.0 (P<0.001). The HAMD response and remission rates were 61.5% (24/39) and 28.2% (11/39), respectively, and the HAMA response rate was 69.2% (27/39). Mean stimulus energy was 10.04% ± 3.72% and mean seizure duration 59.34 ± 16.11 s, with a moderate negative correlation (ρ=−0.58, P<0.001). The reduced five-variable model identified no significant independent predictors of response (apparent AUC = 0.783; optimism-corrected AUC = 0.678); an exploratory 12-variable model (apparent AUC = 0.886) showed a nominally significant association for male sex (P = 0.037) but exhibited quasi-complete separation, and all predictor analyses were exploratory and hypothesis-generating. Sensitivity analyses yielded consistent results.
Conclusions
MECT under etomidate–succinylcholine anesthesia was associated with clinically meaningful short-term improvement in depressed patients aged ≤30 years. Given the small single-center retrospective sample, these exploratory findings require confirmation in larger prospective studies.
Zitieren
APA
Sun, X., Cai, M., Shen, Y., Ding, C., & Li, W. (2026). Real-world efficacy and predictors of response to modified electroconvulsive therapy in patients with depression aged ≤30 years: a retrospective observational study. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1969515
Vancouver
Sun X, Cai M, Shen Y, Ding C, Li W. Real-world efficacy and predictors of response to modified electroconvulsive therapy in patients with depression aged ≤30 years: a retrospective observational study. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1969515
BibTeX
@article{Sun2026,
author = {Sun, Xiaoli and Cai, Mingjian and Shen, Yonghui and Ding, Chao and Li, Wanwen},
title = {Real-world efficacy and predictors of response to modified electroconvulsive therapy in patients with depression aged ≤30 years: a retrospective observational study},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1969515}
}
EUVIMED